Macquarie Group LTD Albireo Pharma, Inc. Transaction History

Macquarie Group LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$16.32 - $26.37 $6,609 - $10,679	-405 Closed	0 $8,000
Q1 2021 May 14, 2021	BUY	$32.03 - $42.85 $12,972 - $17,354	405 New	405 $14,000
Q1 2018 May 11, 2018	SELL	$26.78 - $39.35 $8,034 - $11,805	-300 Closed	0 $0
Q4 2017 Feb 15, 2018	BUY	$21.56 - $28.14 $6,468 - $8,442	300	300 $8,000

865

Ticker ALBO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 19,612,500
Description
Albireo Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel bile acid modulators to treat orphan pediatric liver diseases and other liver or gastrointestinal diseases and disorders. The company offers Bylvay for the treatment of progressive familial intrahepatic cholestasis, as we...

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

Stay updated on Macquarie Group LTD with notifications on news.